APA (7th ed.) Citation

F, S. H., L, v. d. S., AP, K., MHJ, v. O., WFM, P., MED, C., . . . MD, L. (2020). Proteomic markers with prognostic impact on outcome of chronic lymphocytic leukemia patients under chemo-immunotherapy: Results from the HOVON 109 study. Experimental hematology, 89, 55. https://doi.org/10.1016/j.exphem.2020.08.002

Chicago Style (17th ed.) Citation

F, Saberi Hosnijeh, et al. "Proteomic Markers with Prognostic Impact on Outcome of Chronic Lymphocytic Leukemia Patients Under Chemo-immunotherapy: Results from the HOVON 109 Study." Experimental Hematology 89 (2020): 55. https://doi.org/10.1016/j.exphem.2020.08.002.

MLA (9th ed.) Citation

F, Saberi Hosnijeh, et al. "Proteomic Markers with Prognostic Impact on Outcome of Chronic Lymphocytic Leukemia Patients Under Chemo-immunotherapy: Results from the HOVON 109 Study." Experimental Hematology, vol. 89, 2020, p. 55, https://doi.org/10.1016/j.exphem.2020.08.002.